Virtus Biotech Clinical Trials ETF (BBC)'s 30-day implied volatility (IV30) was 48.0% at the close on November 6, 2026, up from 45.0% the day before, against a 52-week range of 27.1% to 45.9%. Its 20-day historical volatility was 53.1%.
Data as of November 6, 2026.